PNS29 How Much Savings Mabthera's and Herceptin's Biosimilars Generated in France?

Autor:	B. Tehard, F. Chassagnol, C. Chamielec
Rok vydání:	2020
Předmět:	Health Policy Public Health Environmental and Occupational Health Biosimilar
Zdroj:	Value in Health. 23:S648
ISSN:	1098-3015
DOI:	10.1016/j.jval.2020.08.1473
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cb82ae16636b4b760da87c9ce24a275b https://doi.org/10.1016/j.jval.2020.08.1473 Zobrazit plný text záznamu Full Text from ScienceDirect